88 related articles for article (PubMed ID: 32847469)
1. Communities and Clinical Trials: A Case Study from the RTS,S Malaria Vaccine Trials in Eastern Africa.
Wyss-van den Berg M; Ogutu B; Sewankambo NK; Merten S; Biller-Andorno N; Tanner M
J Empir Res Hum Res Ethics; 2020 Dec; 15(5):465-477. PubMed ID: 32847469
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials in low-resource settings: the perspectives of caregivers of paediatric participants from Uganda, Tanzania and Kenya.
van den Berg M; Ogutu B; Sewankambo NK; Merten S; Biller-Andorno N; Tanner M
Trop Med Int Health; 2019 Aug; 24(8):1023-1030. PubMed ID: 31215122
[TBL] [Abstract][Full Text] [Related]
3. RTS,S malaria vaccine pilot studies: addressing the human realities in large-scale clinical trials.
van den Berg M; Ogutu B; Sewankambo NK; Biller-Andorno N; Tanner M
Trials; 2019 May; 20(1):316. PubMed ID: 31151473
[TBL] [Abstract][Full Text] [Related]
4. Community perceptions on the secondary health benefits established by malaria vaccine trials (RTS,S phase 2 and phase 3) at the Korogwe site in North Eastern Tanzania.
Liheluka EA; Lusingu JP; Manongi RN
Malar J; 2013 May; 12():157. PubMed ID: 23651535
[TBL] [Abstract][Full Text] [Related]
5. The Ethics of Health Care Delivery in a Pediatric Malaria Vaccine Trial: The Perspectives of Stakeholders From Ghana and Tanzania.
Ward CL; Shaw D; Anane-Sarpong E; Sankoh O; Tanner M; Elger B
J Empir Res Hum Res Ethics; 2018 Feb; 13(1):26-41. PubMed ID: 29179625
[TBL] [Abstract][Full Text] [Related]
6. Vaccines for preventing malaria.
Graves P; Gelband H
Cochrane Database Syst Rev; 2003; (1):CD000129. PubMed ID: 12535387
[TBL] [Abstract][Full Text] [Related]
7. Caregiver and community perceptions and experiences participating in an infant malaria prevention trial of PfSPZ Vaccine administered by direct venous inoculation: a qualitative study in Siaya County, western Kenya.
Achieng F; Rosen JG; Cherop RY; Kariuki S; Hoffman SL; Seder R; Oneko M; Steinhardt LC
Malar J; 2020 Jun; 19(1):226. PubMed ID: 32580719
[TBL] [Abstract][Full Text] [Related]
8. Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I-III trials.
Agnandji ST; Fernandes JF; Bache EB; Ramharter M
Future Microbiol; 2015; 10(10):1553-78. PubMed ID: 26437872
[TBL] [Abstract][Full Text] [Related]
9. Sustainable development of a GCP-compliant clinical trials platform in Africa: the malaria clinical trials alliance perspective.
Ogutu BR; Baiden R; Diallo D; Smith PG; Binka FN
Malar J; 2010 Apr; 9():103. PubMed ID: 20406478
[TBL] [Abstract][Full Text] [Related]
10. [The malaria vaccine candidate RTS,S/AS is in phase III clinical trials].
Cohen J; Benns S; Vekemans J; Leach A
Ann Pharm Fr; 2010 Nov; 68(6):370-9. PubMed ID: 21073995
[TBL] [Abstract][Full Text] [Related]
11. The RTS,S malaria vaccine.
Casares S; Brumeanu TD; Richie TL
Vaccine; 2010 Jul; 28(31):4880-94. PubMed ID: 20553771
[TBL] [Abstract][Full Text] [Related]
12. Vaccines for preventing malaria (pre-erythrocytic).
Graves P; Gelband H
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD006198. PubMed ID: 17054280
[TBL] [Abstract][Full Text] [Related]
13. Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa.
Guerra Mendoza Y; Garric E; Leach A; Lievens M; Ofori-Anyinam O; Pirçon JY; Stegmann JU; Vandoolaeghe P; Otieno L; Otieno W; Owusu-Agyei S; Sacarlal J; Masoud NS; Sorgho H; Tanner M; Tinto H; Valea I; Mtoro AT; Njuguna P; Oneko M; Otieno GA; Otieno K; Gesase S; Hamel MJ; Hoffman I; Kaali S; Kamthunzi P; Kremsner P; Lanaspa M; Lell B; Lusingu J; Malabeja A; Aide P; Akoo P; Ansong D; Asante KP; Berkley JA; Adjei S; Agbenyega T; Agnandji ST; Schuerman L
Hum Vaccin Immunother; 2019; 15(10):2386-2398. PubMed ID: 31012786
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.
Mahmoudi S; Keshavarz H
Hum Vaccin Immunother; 2017 Sep; 13(9):2098-2101. PubMed ID: 28272979
[TBL] [Abstract][Full Text] [Related]
15. Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique.
Campo JJ; Sacarlal J; Aponte JJ; Aide P; Nhabomba AJ; Dobaño C; Alonso PL
Vaccine; 2014 Apr; 32(19):2209-16. PubMed ID: 24631081
[TBL] [Abstract][Full Text] [Related]
16. The development of the RTS,S malaria vaccine candidate: challenges and lessons.
Ballou WR
Parasite Immunol; 2009 Sep; 31(9):492-500. PubMed ID: 19691554
[TBL] [Abstract][Full Text] [Related]
17. Feedback of research findings for vaccine trials: experiences from two malaria vaccine trials involving healthy children on the Kenyan Coast.
Gikonyo C; Kamuya D; Mbete B; Njuguna P; Olotu A; Bejon P; Marsh V; Molyneux S
Dev World Bioeth; 2013 Apr; 13(1):48-56. PubMed ID: 23433355
[TBL] [Abstract][Full Text] [Related]
18. Malaria vaccines in Africa.
Kilama WL
Acta Trop; 2003 Oct; 88(2):153-9. PubMed ID: 14516927
[TBL] [Abstract][Full Text] [Related]
19. Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial.
Aponte JJ; Aide P; Renom M; Mandomando I; Bassat Q; Sacarlal J; Manaca MN; Lafuente S; Barbosa A; Leach A; Lievens M; Vekemans J; Sigauque B; Dubois MC; Demoitié MA; Sillman M; Savarese B; McNeil JG; Macete E; Ballou WR; Cohen J; Alonso PL
Lancet; 2007 Nov; 370(9598):1543-51. PubMed ID: 17949807
[TBL] [Abstract][Full Text] [Related]
20. Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
Baral R; Levin A; Odero C; Pecenka C; Tabu C; Mwendo E; Bonsu G; Bawa J; Dadzie JF; Charo J; Antwi-Agyei KO; Amponsa-Achianou K; Jalango RE; Mkisi R; Gordon S; Mzengeza T; Morgan W; Muhib F
PLoS One; 2021; 16(1):e0244995. PubMed ID: 33428635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
